Auddia Announces Higher Than Expected Success in User Retention and[...]
Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of[...]
Unicycive Therapeutics Announces Late-Breaker Poster Presentation on[...]
10/14/2024 | Press release | Distributed by Public on 10/14/2024 05:04
Please select the service you want to use:
Smartlinks | BioCryst Pharmaceuticals Inc. | News | Health | Company News | Securities Issuers | Pharmaceutical Companies | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Bolsa Mexicana de Valores (BMV) | BX Swiss | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Bolsa Institucional de Valores (BIVA) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact